Drug major Sun Pharmaceutical Industries Ltd on Friday said it closed the first quarter of the current fiscal with a net loss of Rs 151.46 crore.
In a regulatory filing at BSE, the company said it posted a net loss of Rs 151.46 crore for the quarter ended June 30, 2016 as compared to net loss of Rs 396.35 crore for the quarter ended June 30, 2015.
The company's total income decreased from Rs 2,103.67 crore for the quarter ended June 30, 2015 to Rs 1,904.70 crore for the quarter ended June 30, 2016.
--IANS
vj/kb/dg
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app